APO Research
Talk to an analyst

APO RESEARCH · REPORT

Avapritinib Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Avapritinib Tablets Market Outlook and Growth Opportunities 2026

27 December 2025199 pages

Choose your research edition.

Industry ResearchAvapritinib Tablets Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Avapritinib Tablets Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Avapritinib Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Avapritinib Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Avapritinib Tablets Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Avapritinib Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Avapritinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Avapritinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Avapritinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Avapritinib Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Avapritinib Tablets market include Blueprint Medicines and CStone Pharmaceuticals among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Avapritinib Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Avapritinib Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Avapritinib Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Avapritinib Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Avapritinib Tablets Segment by Company

Blueprint Medicines

CStone Pharmaceuticals

Avapritinib Tablets Segment by Type

100mg/pc

200mg/pc

300mg/pc

Others

Avapritinib Tablets Segment by Application

In-hospital Sales

Out-of-hospital Sales

Avapritinib Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Avapritinib Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Avapritinib Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Avapritinib Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Avapritinib Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Avapritinib Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Avapritinib Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Avapritinib Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Avapritinib Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Avapritinib Tablets industry.

Chapter 3: Detailed analysis of Avapritinib Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Avapritinib Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Avapritinib Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Avapritinib Tablets Industry Trends Table 2. Avapritinib Tablets Industry Drivers Table 3. Avapritinib Tablets Industry Opportunities and Challenges Table 4. Avapritinib Tablets Industry Restraints Table 5. Global Avapritinib Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Avapritinib Tablets Revenue Share by Company (2021-2026) Table 7. Global Avapritinib Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Avapritinib Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Avapritinib Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Avapritinib Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Avapritinib Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Avapritinib Tablets Company, Product Type & Application Table 13. Global Avapritinib Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Avapritinib Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 100mg/pc Table 18. Significant Companies of 200mg/pc Table 19. Significant Companies of 300mg/pc Table 20. Significant Companies of Others Table 21. Global Avapritinib Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Avapritinib Tablets Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Avapritinib Tablets Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Avapritinib Tablets Sales Volume Share by Type (2021-2026) Table 25. Global Avapritinib Tablets Sales Volume Share by Type (2027-2032) Table 26. Global Avapritinib Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Avapritinib Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Avapritinib Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Avapritinib Tablets Sales Value Share by Type (2021-2026) Table 30. Global Avapritinib Tablets Sales Value Share by Type (2027-2032) Table 31. Significant Companies of In-hospital Sales Table 32. Significant Companies of Out-of-hospital Sales Table 33. Global Avapritinib Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Avapritinib Tablets Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Avapritinib Tablets Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Avapritinib Tablets Sales Volume Share by Application (2021-2026) Table 37. Global Avapritinib Tablets Sales Volume Share by Application (2027-2032) Table 38. Global Avapritinib Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Avapritinib Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Avapritinib Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Avapritinib Tablets Sales Value Share by Application (2021-2026) Table 42. Global Avapritinib Tablets Sales Value Share by Application (2027-2032) Table 43. Global Avapritinib Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Avapritinib Tablets Sales by Region (2021-2026) & (K Units) Table 45. Global Avapritinib Tablets Sales Market Share by Region (2021-2026) Table 46. Global Avapritinib Tablets Sales by Region (2027-2032) & (K Units) Table 47. Global Avapritinib Tablets Sales Market Share by Region (2027-2032) Table 48. Global Avapritinib Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Avapritinib Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Avapritinib Tablets Sales Value Share by Region (2021-2026) Table 51. Global Avapritinib Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Avapritinib Tablets Sales Value Share by Region (2027-2032) Table 53. Global Avapritinib Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Avapritinib Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Avapritinib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Avapritinib Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Avapritinib Tablets Sales by Country (2021-2026) & (K Units) Table 58. Global Avapritinib Tablets Sales Market Share by Country (2021-2026) Table 59. Global Avapritinib Tablets Sales by Country (2027-2032) & (K Units) Table 60. Global Avapritinib Tablets Sales Market Share by Country (2027-2032) Table 61. Global Avapritinib Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Avapritinib Tablets Sales Value Market Share by Country (2021-2026) Table 63. Global Avapritinib Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Avapritinib Tablets Sales Value Market Share by Country (2027-2032) Table 65. Blueprint Medicines Company Information Table 66. Blueprint Medicines Business Overview Table 67. Blueprint Medicines Avapritinib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Blueprint Medicines Avapritinib Tablets Product Portfolio Table 69. Blueprint Medicines Recent Development Table 70. CStone Pharmaceuticals Company Information Table 71. CStone Pharmaceuticals Business Overview Table 72. CStone Pharmaceuticals Avapritinib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. CStone Pharmaceuticals Avapritinib Tablets Product Portfolio Table 74. CStone Pharmaceuticals Recent Development Table 75. Key Raw Materials Table 76. Raw Materials Key Suppliers Table 77. Avapritinib Tablets Distributors List Table 78. Avapritinib Tablets Customers List Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Avapritinib Tablets Product Image Figure 2. Global Avapritinib Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Avapritinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Avapritinib Tablets Sales (2021-2032) & (K Units) Figure 5. Global Avapritinib Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Avapritinib Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 100mg/pc Image Figure 10. 200mg/pc Image Figure 11. 300mg/pc Image Figure 12. Others Image Figure 13. Global Avapritinib Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Avapritinib Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Avapritinib Tablets Sales Volume Share by Type (2021-2032) Figure 16. Global Avapritinib Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Avapritinib Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Avapritinib Tablets Sales Value Share by Type (2021-2032) Figure 19. In-hospital Sales Image Figure 20. Out-of-hospital Sales Image Figure 21. Global Avapritinib Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Avapritinib Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Avapritinib Tablets Sales Volume Share by Application (2021-2032) Figure 24. Global Avapritinib Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Avapritinib Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Avapritinib Tablets Sales Value Share by Application (2021-2032) Figure 27. Global Avapritinib Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Avapritinib Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Avapritinib Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Avapritinib Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Avapritinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. North America Avapritinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Avapritinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Avapritinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Avapritinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Avapritinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Avapritinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. South America Avapritinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Avapritinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Avapritinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Avapritinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Avapritinib Tablets Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Avapritinib Tablets Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg/pc
  • 200mg/pc
  • 300mg/pc
  • Others
Applications
  • In-hospital Sales
  • Out-of-hospital Sales
Companies covered
  • Blueprint Medicines
  • CStone Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Avapritinib Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Avapritinib Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Avapritinib Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Avapritinib Tablets Market Dynamics
  1. 2.1 Avapritinib Tablets Industry Trends
  2. 2.2 Avapritinib Tablets Industry Drivers
  3. 2.3 Avapritinib Tablets Industry Opportunities and Challenges
  4. 2.4 Avapritinib Tablets Industry Restraints
3 Avapritinib Tablets Market by Company
  1. 3.1 Global Avapritinib Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Avapritinib Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Avapritinib Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Avapritinib Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Avapritinib Tablets Company Ranking (2024-2026)
  6. 3.6 Global Avapritinib Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Avapritinib Tablets Company Product Type and Application
  8. 3.8 Global Avapritinib Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Avapritinib Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Avapritinib Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Avapritinib Tablets Market by Type
  1. 4.1 Avapritinib Tablets Type Introduction
  2. 4.1.1 100mg/pc
  3. 4.1.2 200mg/pc
  4. 4.1.3 300mg/pc
  5. 4.1.4 Others
  6. 4.2 Global Avapritinib Tablets Sales Volume by Type
  7. 4.2.1 Global Avapritinib Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Avapritinib Tablets Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Avapritinib Tablets Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Avapritinib Tablets Sales Value by Type
  11. 4.3.1 Global Avapritinib Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Avapritinib Tablets Sales Value by Type (2021-2032)
  13. 4.3.3 Global Avapritinib Tablets Sales Value Share by Type (2021-2032)
5 Avapritinib Tablets Market by Application
  1. 5.1 Avapritinib Tablets Application Introduction
  2. 5.1.1 In-hospital Sales
  3. 5.1.2 Out-of-hospital Sales
  4. 5.2 Global Avapritinib Tablets Sales Volume by Application
  5. 5.2.1 Global Avapritinib Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Avapritinib Tablets Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Avapritinib Tablets Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Avapritinib Tablets Sales Value by Application
  9. 5.3.1 Global Avapritinib Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Avapritinib Tablets Sales Value by Application (2021-2032)
  11. 5.3.3 Global Avapritinib Tablets Sales Value Share by Application (2021-2032)
6 Avapritinib Tablets Regional Sales and Value Analysis
  1. 6.1 Global Avapritinib Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Avapritinib Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Avapritinib Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Avapritinib Tablets Sales by Region (2027-2032)
  5. 6.3 Global Avapritinib Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Avapritinib Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Avapritinib Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Avapritinib Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Avapritinib Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Avapritinib Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Avapritinib Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Avapritinib Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Avapritinib Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Avapritinib Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Avapritinib Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Avapritinib Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Avapritinib Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Avapritinib Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Avapritinib Tablets Sales Value Share by Country, 2025 VS 2032
7 Avapritinib Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Avapritinib Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Avapritinib Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Avapritinib Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Avapritinib Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Avapritinib Tablets Sales by Country (2027-2032)
  6. 7.4 Global Avapritinib Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Avapritinib Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Avapritinib Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Avapritinib Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Avapritinib Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Avapritinib Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Blueprint Medicines
  2. 8.1.1 Blueprint Medicines Company Information
  3. 8.1.2 Blueprint Medicines Business Overview
  4. 8.1.3 Blueprint Medicines Avapritinib Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Blueprint Medicines Avapritinib Tablets Product Portfolio
  6. 8.1.5 Blueprint Medicines Recent Developments
  7. 8.2 CStone Pharmaceuticals
  8. 8.2.1 CStone Pharmaceuticals Company Information
  9. 8.2.2 CStone Pharmaceuticals Business Overview
  10. 8.2.3 CStone Pharmaceuticals Avapritinib Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 CStone Pharmaceuticals Avapritinib Tablets Product Portfolio
  12. 8.2.5 CStone Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Avapritinib Tablets Value Chain Analysis
  2. 9.1.1 Avapritinib Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Avapritinib Tablets Sales Mode & Process
  6. 9.2 Avapritinib Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Avapritinib Tablets Distributors
  9. 9.2.3 Avapritinib Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst